Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
57 studies found for:    "Adrenocortical carcinoma"
Show Display Options
Rank Status Study
1 Active, not recruiting Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Dovitinib
2 Completed Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: cisplatin, taxotere
3 Recruiting German Adrenocortical Carcinoma Registry
Condition: Adrenocortical Carcinoma
Intervention:
4 Completed A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Interventions: Drug: OSI-906;   Other: Placebo
5 Unknown  Sunitinib in Refractory Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Sunitinib
6 Completed Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Condition: Nonresectable Adrenocortical Carcinoma
Intervention: Drug: Iressa (ZD1839)
7 Completed Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention:
8 Recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab
9 Terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Interventions: Drug: suramin;   Drug: therapeutic hydrocortisone
10 Withdrawn Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Bevacizumab
11 Unknown  Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
Condition: Adrenocortical Carcinoma
Interventions: Drug: Sorafenib;   Drug: Paclitaxel
12 Recruiting Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Peritoneal Carcinomatosis
Interventions: Drug: Cisplatin;   Procedure: Cytoreductive surgery;   Drug: sodium thiosulfate
13 Active, not recruiting Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Cushing's Syndrome
Intervention:
14 Completed A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
Condition: Adrenal Cortical Carcinoma
Intervention: Drug: doxorubicin, vincristine, and etoposide with mitotane
15 Recruiting Evaluation of Side Effects of Mitotane
Condition: Adrenocortical Carcinoma
Intervention:
16 Terminated Possible New Therapy for Advanced Cancer
Condition: Adrenocortical Carcinoma
Intervention: Drug: IL-13-PE
17 Unknown  Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Condition: Adrenocortical Carcinoma
Intervention: Drug: MITOTANE
18 Recruiting Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Adrenal Cancer;   ACC
Intervention: Drug: ATR-101
19 Completed
Has Results
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Recurrent Adrenocortical Carcinoma;   Stage III Adrenocortical Carcinoma;   Stage IV Adrenocortical Carcinoma
Intervention: Drug: R-(-)-gossypol acetic acid
20 Completed Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
Condition: Adrenocortical Carcinoma
Interventions: Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: nucleic acid sequencing;   Genetic: polymorphism analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.